← Scroll for more →
Supernus Pharmaceuticals, Inc. (SUPN)
Pharmaceutical Preparations
Latest Price
$41.92
TTM P/E
--
Normalized P/E
201.54
TTM Div Yield
--
Fwd Div Yield
--
Book Value
18.28
P/B Ratio
2.29
Valuation metrics
adjust assumptions →Norm. op. income: $84M (median of 6yr)
Tax rate: 25%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$19.66
52% downside
Base FCF: $138M (median of recent 4yr)
Growth: -4%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$30.09
27% downside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.35M | $434.0M | 16.08% | +552.8K | 2026-06-30 |
| Millennium Management LLC | 3.85M | $179.0M | 6.62% | +537.2K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 3.31M | $153.0M | 5.68% | +66.7K | 2026-06-30 |
| Armistice Capital, LLC | 2.65M | $123.0M | 4.55% | +750.9K | 2026-06-30 |
| Vanguard Capital Management LLC | 2.52M | $117.0M | 4.33% | +49.5K | 2026-06-30 |
| State Street Corp | 2.46M | $114.0M | 4.23% | +171.7K | 2026-06-30 |
| Nomura Asset Management International Inc. | 2.38M | $110.0M | 4.09% | +341.1K | 2026-06-30 |
| Dimensional Fund Advisors LP | 2.08M | $96.0M | 3.57% | -228.9K | 2026-06-30 |
| Geode Capital Management, LLC | 1.57M | $73.0M | 2.70% | -53.4K | 2026-06-30 |
| Stephens Investment Management Group LLC | 1.49M | $69.0M | 2.55% | +134.5K | 2026-06-30 |